UK regulator approves Eli Lilly's oral GLP-1 pill orforglipron (Foundayo)
The UK's Medicines and Healthcare products Regulatory Agency approved Eli Lilly's once-daily oral GLP-1 pill orforglipron (branded Foundayo) for weight management and type 2 diabetes, making Britain the first country in Europe to authorize the drug.
Detected & updated continuously · Source: Nebula
Story subjects
Sources
@qz
Eli Lilly's weight-loss pill is approved in the U.K.: The U.K. regulator authorized orforglipron for weight management and type 2 diabetes, making Britain the first country in Europe to clear the drug https://t.co/yvHdZBWSDB https://t.co/6mnid26Wcz
@improvethenews
The U.K.'s Medicines and Healthcare products Regulatory Agency approved Foundayo, made by Eli Lilly, on Monday, making Britain the first country in Europe to authorize the once-daily oral GLP-1 pill for weight management and type 2 diabetes. https://t.co/7EFbQlF410